The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
An International Nursing Panel on the Role of Nurses Related to Addictions/Substance Use Disorders - Dana Murphy-Parker- MS, PMHNP-BC, CARN-AP, FIAAN;Adam Searby, RN, PhD;Adrian Jugdoyal, PG Dip, PGCAP, BSc (Ho…P, TCH, FHEA); Divane de, Day 4, 13:30-15:00
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022.
Assessing the Life Skills Of Street Children Who Use Substances in Calabar Metropolis, Cross River State, Nigeria - Asu Obasse Benedict, Day 4, 11:00-12:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022.
Models of Recovery: influence of psychosocial factors on substance use recovery - Antonio Molina Fernandes, Day 4, 11:00-12:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022
HCV prevention, testing and treatment for people who inject drugs: A global and country perspective
ISSUP are pleased to present this webinar on hepatitis C care for people who inject drugs.
HCV prevention, testing and treatment for people who inject drugs: A global and country perspective
ISSUP would like to invite you to attend an upcoming webinar on hepatitis C care for people who inject drugs.
Patient Journey Map Substance Use Disorder Treatment and Recovery Experiences
About the Report Addiction Policy Forum’s (APF) Patient Experiences Journey Map was developed through the input of patients in treatment and recovery from substance use disorder (SUD). The map underscores the obstacles and positive points...
Bupropion and Naltrexone in Methamphetamine Use Disorder
Abstract Background The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied. Methods We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a sequential...
Treatment, Day 3, Track 3, 13:30-15:00
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022
Epidemiology, Day 3, Track 3, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022
Drug Policy, Day 3, Track 2, 13:30-15:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022 Presentations: ETHOS: the small word that defines us - Phaedon Kaloterakis How investing in advocacy can improve the...